Login / Signup

Punicalagin Induces Serum Low-Density Lipoprotein Influx to Macrophages.

Dana AtrahimovichSoliman KhatibShifra SelaJacob VayaAbraham O Samson
Published in: Oxidative medicine and cellular longevity (2016)
High levels of circulating low-density lipoprotein (LDL) are a primary initiating event in the development of atherosclerosis. Recently, the antiatherogenic effect of polyphenols has been shown to be exerted via a mechanism unrelated to their antioxidant capacity and to stem from their interaction with specific intracellular or plasma proteins. In this study, we investigated the interaction of the main polyphenol in pomegranate, punicalagin, with apolipoprotein B-100 (ApoB100) that surrounds LDL. Punicalagin bound to ApoB100 at low concentrations (0.25-4 μM). Upon binding, it induced LDL influx to macrophages in a concentration-dependent manner, up to 2.5-fold. In contrast, another polyphenol which binds to ApoB100, glabridin, did not affect LDL influx. We further showed that LDL influx occurs specifically through the LDL receptor, with LDL then accumulating in the cell cytoplasm. Taken together with the findings of Aviram et al., 2000, that pomegranate juice and punicalagin induce plasma LDL removal and inhibit macrophage cholesterol synthesis and accumulation, our results suggest that, upon binding, punicalagin stimulates LDL influx to macrophages, thus reducing circulating cholesterol levels.
Keyphrases
  • low density lipoprotein
  • magnetic resonance
  • stem cells
  • type diabetes
  • adipose tissue
  • magnetic resonance imaging
  • bone marrow
  • mass spectrometry
  • dna binding